'Dramatic' early phase 1 results for AG-120 in IDH1 mutated AML
2014-11-25
(Press-News.org) Results presented November 19 by University of Colorado Cancer Center investigator Daniel Pollyea, MD, MS, at the 26th European Organisation for Research and Treatment of Cancer Symposium in Barcelona show "extremely promising" early phase 1 clinical trial results for the investigational drug AG-120 against the subset of patients with acute myeloid leukemia (AML) harboring mutations in the gene IDH1. The finding builds on phase 1 results of a related drug, AG-221, against IDH2 mutations, presented at the most recent meeting of the American Association for Cancer Research. The IDH1 mutation is found in 15-20 percent of all cases of AML, totaling about 3,500 cases of IDH1 AML per year.
"This is one of the most exciting developments in AML in a long time," Pollyea says. He cautions that results at this stage are preliminary and based on only 17 patients, but says, "Results have been dramatic."
The gene IDH1 is normally involved in regulation of the Krebs cycle, a cellular energy pathway. When IDH1 is mutated it sets off a chain reaction that results in the failure of cells to mature, allowing for the development of AML. In preclinical studies, the drug AG-120 was shown to block the abnormal function of mutated IDH1, restoring natural development and leading to the orderly death of leukemia cells.
Based on strong phase 1 clinical trial results, the U.S. Food and Drug Administration recently granted Fast Track designation to the sister drug, AG-221, targeting the IDH2 mutation. There is reason to be equally optimistic about AG-120. "This is a high-risk population and we hope that with continued successes we'll be able to offer this therapy to more and more patients participating in this clinical trial," Pollyea said.
Pollyea explains that the clinical trial offered at the University of Colorado Hospital, the primary clinical care partner of the University of Colorado Cancer Center, is mainly for AML patients that have relapsed after previous treatments. "The test for the IDH mutation is done next door by the molecular lab at Children's Hospital Colorado and we now offer the assay as a standard test for patients diagnosed with AML so that in the case of relapse we can quickly offer the clinical trial," Pollyea says.
The AG-120 phase 1 clinical trial for IDH1 mutant AML is also offered at Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center, as well as a select number of other academic hospitals.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2014-11-25
After mining the genetic records of thousands of breast cancer patients, researchers from the Johns Hopkins Kimmel Cancer Center have identified a gene whose presence may explain why some breast cancers are resistant to tamoxifen, a widely used hormone treatment generally used after surgery, radiation and other chemotherapy.
The gene, called MACROD2, might also be useful in screening for some aggressive forms of breast cancers, and, someday, offering a new target for therapy, says Ben Ho Park, M.D., Ph.D., an associate professor of oncology in the Kimmel Cancer Center's ...
2014-11-25
A new expert panel report, Policing Canada in the 21st Century: New Policing for New Challenges, released today by the Council of Canadian Academies, details the complexity and global nature of policing in the modern age. Overall, a 12-member Expert Panel determined that safety and security cannot just rest with Canada's policing services. Specialists, public and private security services, and other first responders all have a vital role to play in an interconnected safety and security web. This transition has already begun in Canada and around the world. A central challenge ...
2014-11-25
The treatment of people who cannot keep their gambling habits in check is often complicated because they also tend to suffer from personality disorders. So says Meredith Brown of Monash University in Australia, in a review in Springer's Journal of Gambling Studies.
Problem gambling creates a multitude of intrapersonal, interpersonal and social difficulties for the roughly 2.3 percent of the population internationally that suffers from this behavior. Previous research has shown that people with gambling problems suffer from a range of psychiatric disorders affecting their ...
2014-11-25
Genes make proteins and proteins tell your body's cells what to do: one talks to the next, which talks to the next, and to the next. Like a game of telephone, researchers call these "signaling pathways". Abnormalities in these signaling pathways can cause the growth and survival of cancer cells. Commonly, mutations or rearrangements of genes in the MAPK signaling pathway create cancer's fast growth, and alterations in the PI3K signaling pathway allow cancer cells to survive into virtual immortality.
Of course, researchers have extensively targeted these two signaling ...
2014-11-25
FRANKFURT/GIESSEN. Healthy cells reduce their growth when there is a lack of oxygen (hypoxia). This makes it even more surprising that hypoxia is a characteristic feature of malignant tumours. In two publications in the current edition of the "Nature Communications" journal, researchers from Goethe University and Justus-Liebig-University of Giessen report on how cancer cells succeed at circumventing the genetic program of growth inhibition.
It has long been known that PHD proteins (prolyl-hydroxylase domain proteins) play a key role among the regulators of hypoxia. They ...
2014-11-25
CHICAGO - Researchers have developed a new device that may result in more comfortable mammography for women. According to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA), standardizing the pressure applied in mammography would reduce pain associated with breast compression without sacrificing image quality.
Compression of the breast is necessary in mammography to optimize image quality and minimize absorbed radiation dose. However, mechanical compression of the breast in mammography often causes discomfort and ...
2014-11-25
CHICAGO - In a study of nearly 2,000 adults, researchers found that a buildup of plaque in the body's major arteries was associated with mild cognitive impairment. Results of the study conducted at the University of Texas (UT) Southwestern Medical Center will be presented next week at the annual meeting of the Radiological Society of North America (RSNA).
"It is well established that plaque buildup in the arteries is a predictor of heart disease, but the relationship between atherosclerosis and brain health is less clear," said Christopher D. Maroules, M.D., radiology ...
2014-11-25
Expensive tests for measuring everything from sperm motility to cancer diagnosis have just been made hundreds of thousands of pounds cheaper by a PhD student from Brunel University London who hacked his own microscope.
Adam Lynch, from the university's College of Health and Life Sciences, created his own inverted microscope by adapting a cheap instrument he bought online to save himself time and money.
The tool is used to measure cell motility - how fast cells move from one place to another - but the high-quality equipment, used to automatically test multiple samples, ...
2014-11-25
Extreme weather events, such as El Niño, can have long-lasting effects on health, according to research published in the open access journal Climate Change Responses. The study, in coastal Peru, shows that children born during and after the 1997-98 El Niño have a lower height-for-age than others born before the event.
Short stature, otherwise known as stunting, is a measure of chronic malnutrition and this generally persists through to adulthood. The research highlights the need for better understanding of the global health issues that may arise and for the ...
2014-11-25
A high intake of yogurt has been found to be associated with a lower risk of developing type 2 diabetes, according to research published in open access journal BMC Medicine. This highlights the importance of having yogurt as part of a healthy diet.
Type 2 diabetes is a chronic condition that occurs when the body doesn't produce enough insulin, or the body's cells develop resistance to insulin. There is an increased risk of developing it if a relative has the condition or if an individual has an unhealthy lifestyle. Approximately 366 million people are affected by type ...
LAST 30 PRESS RELEASES:
[Press-News.org] 'Dramatic' early phase 1 results for AG-120 in IDH1 mutated AML
